Literature DB >> 1680125

Benzodiazepine hypnotics: sorting the pharmacokinetic facts.

D J Greenblatt1.   

Abstract

Five benzodiazepine derivatives are currently approved for the treatment of sleep disorders. Important differences exist among the drugs in the physicochemical properties of lipid solubility and protein binding and in pharmacokinetic properties of absorption, distribution, elimination, and clearance. These differences may account for observed variations in clinical action and side effects during and after treatment. Bases for understanding and predicting differences among benzodiazepine hypnotics are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680125

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  The pharmacology of benzodiazepines: comments on terminology and sources of data.

Authors:  D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 2.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 3.  Pharmacological treatment of insomnia.

Authors:  M Maczaj
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 4.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  An assessment of short-acting hypnotics.

Authors:  W B Mendelson; B Jain
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

6.  Medications for the Treatment of Sleep Disorders: An Overview.

Authors:  J F Pagel; Bennett L. Parnes
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.